Health · 3 views
Semaglutide may lower fetal oxygen levels, sheep study suggests
They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilograms.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 45 words
AI Summary
Semaglutide, a weight‑loss drug sold as Ozempic and Wegovy, may affect fetal oxygen levels. A study in sheep found that continued exposure to the drug during pregnancy lowered oxygen delivery to the fetus. The research raises questions about the safety of using semaglutide while pregnant.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- A brief history of the food pyramid—and its many false startsContinue reading
- Putting paternal mental health in the spotlightContinue reading
- Medicare reimbursement rates for dermatology decline 29%, adjusted for inflationContinue reading
- How human movement predicts health measures across multiple body systemsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow